HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 294/2/E232    most recent 00592.2007v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Aigner, B. Articles by Wolf, E. PubMed PubMed Citation Articles by Aigner, B. Articles by Wolf, E.

FRONTIERS

Diabetes models by screen for hyperglycemia in phenotype-driven ENU mouse mutagenesis projects

¹Institute of Molecular Animal Breeding and Biotechnology, Ludwig-Maximilians-University, Munich; ²Institute of Veterinary Pathology, Ludwig-Maximilians-University, Munich; ³Institute of Experimental Genetics, GSF Research Center for Environment and Health, Neuherberg; and ⁴Laboratory for Functional Genome Analysis, Gene Center, Ludwig-Maximilians-University, Munich, Germany

Submitted 11 September 2007 ; accepted in final form 28 November 2007

ABSTRACT

More than 150 million people suffer from diabetes mellitus worldwide, and this number is expected to rise substantially within the next decades. Despite its high prevalence, the pathogenesis of diabetes mellitus is not completely understood. Therefore, appropriate experimental models are essential tools to gain more insight into the genetics and pathogenesis of the disease. Here, we describe the current efforts to establish novel diabetes models derived from unbiased, phenotype-driven, large-scale N-ethyl-N-nitrosourea (ENU) mouse mutagenesis projects started a decade ago using hyperglycemia as a high-throughput screen parameter. Mouse lines were established according to their hyperglycemia phenotype over several generations, thereby revealing a mutation as cause for the aberrant phenotype. Chromosomal assignment of the causative mutation and subsequent candidate gene analysis led to the detection of the mutations that resulted in novel alleles of genes already known to be involved in glucose homeostasis, like glucokinase, insulin 2, and insulin receptor. Additional ENU-induced hyperglycemia lines are under genetic analysis. Improvements in screen for diabetic animals are implemented to detect more subtle phenotypes. Moreover, diet challenge assays are being employed to uncover interactions between genetic and environmental factors in the pathogenesis of diabetes mellitus. The new mouse mutants recovered in phenotype-driven ENU mouse mutagenesis projects complement the available models generated by targeted mutagenesis of candidate genes, all together providing the large resource of models required for a systematic dissection of the pathogenesis of diabetes mellitus.

clinical chemistry; N-ethyl-N-nitrosourea; glucose; insulin